Healthcare
Live Price
Offline$14.32
-1.38% today
1Y Change
-18.11%
Window
Jun 20, 2025 → Jun 9, 2026
Coverage: 243 bars · Jun 20, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sonic Healthcare Limited (SKHHY) is a Healthcare stock with a market cap of $9.86B and listed on OTC. The stock last traded around $14.32 and down 18.1% across the available one-year price window (Jun 20, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of +8.0%, EPS growth of 0.0%, a dividend yield of 5.4%. What stands out right now is revenue +8.0%, EPS 0.0%, free cash flow +95.2% with operating margin 19.0% and ROIC 9.3%. The dividend matters to the case here, with a current yield around 5.4%. Valuation is more restrained than many high-expectation growth names at P/E 18.3 and price/sales 0.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SKHHY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKHHY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SKHHY Max Drawdown
-30.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SKHHY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$8.8B
-6.0% YoY
FY Net Income
$1.3B
-10.0% YoY
Free Cash Flow
$1.7B
-9.1% YoY
Revenue Growth
+8.0%
EPS Growth
+0.0%
Gross Margin
29.6%
Net Margin
5.2%
Income statement
AUD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9.6B | 8.9B | 8.0B | 9.3B | 8.8B |
| Gross Profit | 3.2B | 2.9B | 2.1B | 3.4B | 7.1B |
| Operating Income | 2.9B | 816M | 2.6B | 2.1B | 3.2B |
| EBITDA | 1.7B | 1.7B | 1.7B | 2.8B | 2.6B |
| Net Income | 514M | 511M | 685M | 1.5B | 1.3B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
AUD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 674M | 645M | 798M | 780M | 900M |
| Total Assets | 16.1B | 14.8B | 13.6B | 13.1B | 12.3B |
| Total Liabilities | 7.6B | 6.8B | 5.6B | 5.7B | 5.8B |
| Shareholder Equity | 8.3B | 7.9B | 7.7B | 7.3B | 6.4B |
| Total Debt | 5.2B | 4.5B | 3.1B | 3.0B | 3.2B |
| Net Debt | 4.5B | 3.9B | 2.3B | 2.2B | 2.3B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2.0B
-8.2% YoY
Capital Expenditures
363M
+4.1% YoY
Free Cash Flow
1.7B
-9.1% YoY
Key ratios
Gross Margin
29.6%
Operating Margin
19.0%
Net Margin
5.2%
ROE
6.4%
Debt / Equity
0.86x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.